Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurosci ; 15(12): 1991-2006, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12099905

ABSTRACT

Adult Long-Evans male rats sustained injections of 5,7-dihydroxytryptamine into the fimbria-fornix (2.5 microg/side) and the cingular bundle (1.5 microg/side) and/or to intraseptal injections of 192 IgG-saporin (0.4 microg/side) in order to deprive the hippocampus of its serotonergic and cholinergic innervations, respectively. Sham-operated rats were used as controls. The rats were tested for locomotor activity (postoperative days 18, 42 and 65), spontaneous T-maze alternation (days 20-29), beam-walking sensorimotor (days 34-38), water maze (days 53-64) and radial maze (days 80-133) performances. The cholinergic lesions, which decreased the hippocampal concentration of ACh by about 65%, induced nocturnal hyperlocomotion, reduced T-maze alternation, impaired reference-memory in the water maze and working-memory in the radial maze, but had no effect on beam-walking scores and working-memory in the water maze. The serotonergic lesions, which decreased the serotonergic innervation of the hippocampus by about 55%, failed to induce any behavioural deficit. In the group of rats given combined lesions, all deficits produced by the cholinergic lesions were observed, but the nocturnal hyperlocomotion and the working-memory deficits in the radial maze were attenuated significantly. These results suggest that attenuation of the serotonergic tone in the hippocampus may compensate for some dysfunctions subsequent to the loss of cholinergic hippocampal inputs. This observation is in close concordance with data showing that a reduction of the serotonergic tone, by pharmacological activation of somatodendritic 5-HT(1A) receptors on raphe neurons, attenuates the cognitive disturbances produced by the intrahippocampal infusion of the antimuscarinic drug, scopolamine. This work has been presented previously [Serotonin Club/Brain Research Bulletin conference, Serotonin: From Molecule to the Clinic (satellite to the Society for Neuroscience Meeting, New Orleans, USA, November 2-3, 2000)].


Subject(s)
Acetylcholine/metabolism , Cognition Disorders/metabolism , Hippocampus/physiopathology , Neural Pathways/physiopathology , Neurons/metabolism , Raphe Nuclei/physiopathology , Septal Nuclei/physiopathology , Serotonin/metabolism , 5,7-Dihydroxytryptamine/pharmacology , Acetylcholinesterase/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Behavior, Animal/drug effects , Behavior, Animal/physiology , Cholinergic Agents/pharmacology , Cognition Disorders/chemically induced , Cognition Disorders/physiopathology , Denervation , Drug Interactions , Hippocampus/drug effects , Hippocampus/metabolism , Immunotoxins/pharmacology , Male , Maze Learning/drug effects , Maze Learning/physiology , Motor Activity/drug effects , Motor Activity/physiology , N-Glycosyl Hydrolases , Neural Pathways/injuries , Neural Pathways/metabolism , Neurons/drug effects , Postural Balance/drug effects , Postural Balance/physiology , Raphe Nuclei/injuries , Raphe Nuclei/metabolism , Rats , Rats, Long-Evans , Ribosome Inactivating Proteins, Type 1 , Saporins , Septal Nuclei/injuries , Septal Nuclei/metabolism , Serotonin Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...